The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Open accessAbstract
In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank" agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design. PAPERCLIP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“‘living biobanks’ can provide access to patient-derived cells and organoids from large patient cohorts, and have already been established for different cancers124,151,176–178, genetic diseases such as cystic fibrosis, infectious diseases, chronic obstructive pulmonary disease and inflammatory bowel diseases179”
From Human disease models in drug development (2023) · cites this paper as [151]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Organoids are ideally suited for FPM due to their ease of establishment, similarity with the tissue of origin and tractability158,167 and have been deployed to identify therapeutic leads in a number of tumors168, including rare cancers that tend to be understudied and poorly characterized at the molecular level16,151,169,170.”
From Organoids (2022) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies using in vitro organoids grown from different intestinal tumors [33, 34] showed a strong correlation, functionally and molecularly with their primary tissue counterparts, providing a strong argument in favor of the potential for in vitro systems to model intestinal disease.”
From Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells (2018) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In short, the wild-type human colon organoid line P26n, as previously described in Van De Wetering et al. (2015) was cultured in domes of Cultrex Pathclear Reduced Growth Factor Basement Membrane Extract (BME) (3533-001; Amsbio).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as Van De Wetering et al. (2015)
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“broad clinical implementation of patient-specific disease models, such as PDOs, is currently hindered by low efficiencies in PDO establishment (60–70% success rate on average although, for some tissues, up to 90% have been reported for intestinal organoids151) as well as lengthy generation times and expansion procedures”
From Human disease models in drug development (2023) · cites this paper as [151]
The cited source says what the claim attributes to it.
In the citing paper
“Patient-derived tumor organoid (a.k.a. tumoroid) biobanks can be established from biopsies, surgical resections2,3, and even from Pap brushes4.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [3]
In the citing paper
“The reconstituted TME model recapitulates not only the genetic and phenotypic features of a tumor but also models the functional response of a patient to therapeutic agents [389, 390].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [389]
In the citing paper
“3D patient-derived tumor models of CRC (i.e., organoid and spheroid cultures) allow maintenance and expansion of functionally relevant cell subfractions and harbor the patients' individual genetic lesions (Ishiguro et al., 2017;van de Wetering et al., 2015).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as van de Wetering et al., 2015
In the citing paper
“Furthermore, with recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines), a new generation of cancer cell models is being derived to allow full representation of the histopathological and molecular diversity of tumours (37–42).”
From Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models (2019) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Self-citationA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Self-citationAdjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Self-citationVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Self-citation
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,001
Girda, E., Leiserowitz, G. S., Smith, L. H., & Huang, E. C. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001061 · Cited by 73
Organoid technology in cancer precision medicine
Xia, X., Li, F., He, J., Aji, R., & Gao, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.039 · Cited by 72
Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells
Naumovska, E., Aalderink, G., Valencia, C. W., Kosim, K., Nicolas, A., Brown, S., Vulto, P., Erdmann, K. S., & Kurek, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144964 · Cited by 72
Engineered Plant‐Based Nanocellulose Hydrogel for Small Intestinal Organoid Growth
Curvello, R., Kerr, G., Micati, D., Chan, W. H., Raghuwanshi, V. S., Rosenbluh, J., Abud, H. E., & Garnier, G. (2020) · Advanced Science · doi:10.1002/advs.202002135 · Cited by 73
Jensen, L. H., Rogatto, S. R., Lindebjerg, J., Havelund, B. M., Abildgaard, C., do Canto, L. M., Vagn-Hansen, C., Dam, C., Rafaelsen, S. R., & Hansen, T. F. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02683-4 · Cited by 74
Wallach, T. E., & Bayrer, J. R. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001411 · Cited by 72
3D Culture as a Clinically Relevant Model for Personalized Medicine
Fong, E. L. S., Toh, T. B., Yu, H., & Chow, E. K. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317697251 · Cited by 74
Saengwimol, D., Rojanaporn, D., Chaitankar, V., Chittavanich, P., Aroonroch, R., Boontawon, T., Thammachote, W., Jinawath, N., Hongeng, S., & Kaewkhaw, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-34037-y · Cited by 75
Towards manufacturing of human organoids
Ashok, A., Choudhury, D., Fang, Y., & Hunziker, W. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107460 · Cited by 73
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses
Ramos Zapatero, M., Tong, A., Opzoomer, J. W., O’Sullivan, R., Cardoso Rodriguez, F., Sufi, J., Vlckova, P., Nattress, C., Qin, X., Claus, J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.005 · Cited by 72
Establishment of Pancreatic Organoids from Normal Tissue and Tumors
Driehuis, E., Gracanin, A., Vries, R. G. J., Clevers, H. C., & Boj, S. F. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100192 · Cited by 77
Self-citationGarvey, C. M., Spiller, E. R., Lindsay, D., Chiang, C.-T., Choi, N. C., Agus, D. B., Mallick, P., Foo, J., & Mumenthaler, S. M. (2016) · Scientific Reports · doi:10.1038/srep29752 · Cited by 69
Identification, isolation and characterization of human LGR5-positive colon adenoma cells
Dame, M. K., Attili, D., McClintock, S. D., Dedhia, P. H., Ouillette, P. D., Hardt, O., Chin, A. M., Xue, X., Laliberté, J., Katz, E. L., et al. (2018) · Development · doi:10.1242/dev.153049 · Cited by 69
Stadler, M., Walter, S., Walzl, A., Kramer, N., Unger, C., Scherzer, M., Unterleuthner, D., Hengstschläger, M., Krupitza, G., & Dolznig, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.007 · Cited by 73
Ex vivo culture of intact human patient derived pancreatic tumour tissue
Kokkinos, J., Sharbeen, G., Haghighi, K. S., Ignacio, R. M. C., Kopecky, C., Gonzales‐Aloy, E., Youkhana, J., Timpson, P., Pereira, B., Ritchie, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81299-0 · Cited by 71
Strategies for genetic manipulation of adult stem cell-derived organoids
Menche, C., & Farin, H. F. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00609-8 · Cited by 72
Recent Advances in Three-Dimensional Stem Cell Culture Systems and Applications
Wu, X., Su, J., Wei, J., Jiang, N., & Ge, X. (2021) · Stem Cells International · doi:10.1155/2021/9477332 · Cited by 72
Jung, M., Ghamrawi, S., Du, E. Y., Gooding, J. J., & Kavallaris, M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200690 · Cited by 76
Bosco, N., Goldberg, A., Zhao, X., Mays, J. C., Cheng, P., Johnson, A. F., Bianchi, J. J., Toscani, C., Tommaso, E. D., Katsnelson, L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.029 · Cited by 71
Smabers, L. P., Wensink, G. E., Veríssimo, C. S., Koedoot, E., Pitsa, K.-C., Huismans, M. A., Barón, C. H., Doorn, M., Iersel, L. V., Cirkel, G. A., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02980-6 · Cited by 84
Self-citationRecent progress on the organoids: Techniques, advantages and applications
Liu, X., Zhou, Z., Zhang, Y., Zhong, H., Cai, X., & Guan, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117942 · Cited by 79
Gastrointestinal organoids: How they gut it out
Merker, S. R., Weitz, J., & Stange, D. E. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.08.010 · Cited by 76
Difference Makers: Chromosomal Instability versus Aneuploidy in Cancer
van Jaarsveld, R. H., & Kops, G. J. P. L. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.003 · Cited by 71
Ekert, J. E., Deakyne, J., Pribul-Allen, P., Terry, R., Schofield, C., Jeong, C. G., Storey, J., Mohamet, L., Francis, J., Naidoo, A., et al. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220923332 · Cited by 68
Self-citationAdvances in colon cancer research: in vitro and animal models
Lannagan, T. R. M., Jackstadt, R., Leedham, S. J., & Sansom, O. J. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.12.003 · Cited by 74
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Bareham, B. R., Georgakopoulos, N., Matas‐Céspedes, A., Curran, M., & Saeb‐Parsy, K. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02897-5 · Cited by 71
Organoid Technology: Current Standing and Future Perspectives
Shariati, L., Esmaeili, Y., Javanmard, S. H., Bidram, E., & Amini, A. (2021) · Stem Cells · doi:10.1002/stem.3379 · Cited by 71
Wang, E., Xiang, K., Zhang, Y., & Wang, X.-F. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.10.001 · Cited by 56
Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1
Dreijerink, K. M. A., Timmers, H. T. M., & Brown, M. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0281 · Cited by 69
Novel patient-derived preclinical models of liver cancer
Bresnahan, E. R., Ramadori, P., Heikenwälder, M. F., Zender, L., & Lujambio, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.028 · Cited by 69
Ukai, S., Honma, R., Sakamoto, N., Yamamoto, Y., Phạm, Q. T., Harada, K., Takashima, T., Taniyama, D., Asai, R., Fukada, K., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01492-9 · Cited by 68
Single-cell derived tumor organoids display diversity in HLA class I peptide presentation
Demmers, L. C., Kretzschmar, K., van Hoeck, A., Bar‐Ephraïm, Y. E., van den Toorn, H., Koomen, M., van Son, G. J. F., van Gorp, J., Pronk, A., Smakman, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19142-9 · Cited by 67
Self-citationHinman, S. S., Wang, Y., Kim, R., & Allbritton, N. L. (2020) · Nature Protocols · doi:10.1038/s41596-020-00419-8 · Cited by 65
Genetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer
Norkin, M. N., Ordóñez‐Morán, P., & Huelsken, J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109026 · Cited by 68
Engineering hydrogels for personalized disease modeling and regenerative medicine
Tayler, I. M., & Stowers, R. S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.020 · Cited by 70
Wan, C., Mahara, S., Sun, C. X., Doan, A., Chua, H. K., Xu, D., Bian, J., Li, Y., Zhu, D., Sooraj, D., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf2567 · Cited by 66
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
Ren, X., Chen, W., Yang, Q., Li, X., & Xu, L. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15930 · Cited by 73
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
Sailer, V., Amsberg, G. V., Duensing, S. M., Kirfel, J., Lieb, V., Metzger, E., Offermann, A., Pantel, K., Schüle, R., Taubert, H. W., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00677-z · Cited by 74
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
Otto, C., Schmidt, S., Kastner, C., Denk, S., Kettler, J., Müller, N., Germer, C., Wolf, E., Gallant, P., & Wiegering, A. (2019) · Neoplasia · doi:10.1016/j.neo.2019.10.003 · Cited by 69
Ahmed, N., Kadife, E., Raza, A., Short, M. K., Jubinsky, P. T., & Kannourakis, G. (2020) · Cells · doi:10.3390/cells9030719 · Cited by 69
Organoids to study immune functions, immunological diseases and immunotherapy
Ye, W., Luo, C., Li, C., Huang, J., & Liu, F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.027 · Cited by 67
Bi, J., Newtson, A. M., Zhang, Y., Devor, E. J., Samuelson, M. I., Thiel, K. W., & Leslie, K. K. (2021) · Cancers · doi:10.3390/cancers13122901 · Cited by 69
Geometric engineering of organoid culture for enhanced organogenesis in a dish
Park, S. E., Kang, S., Paek, J., Georgescu, A., Chang, J., Yi, A. Y., Wilkins, B. J., Karakasheva, T. A., Hamilton, K. E., & Huh, D. (2022) · Nature Methods · doi:10.1038/s41592-022-01643-8 · Cited by 67
Atanasova, V. S., Cardona, C. D. J., Hejret, V., Tiefenbacher, A., Mair, T., Tran, L., Pfneissl, J., Draganić, K., Binder, C., Kabiljo, J., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.014 · Cited by 69
Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 69
Fong, E. L. S., Toh, T. B., Lin, Q. X. X., Liu, Z., Hooi, L., Rashid, M. B. M. A., Benoukraf, T., Chow, E. K., Huynh, T. H., & Yu, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.026 · Cited by 67
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
Self-citationDrug Discovery via Human-Derived Stem Cell Organoids
Liu, F., Huang, J., Ning, B., Liu, Z., Chen, S., & Zhao, W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00334 · Cited by 69
The future of precision medicine: towards a more predictive personalized medicine
Elemento, O. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20190197 · Cited by 67
Recent advances in preclinical models for lung squamous cell carcinoma
Pan, Y., Han, H., Labbe, K. E., Zhang, H., & Wong, K. (2021) · Oncogene · doi:10.1038/s41388-021-01723-7 · Cited by 68
Organoids and Colorectal Cancer
Barbáchano, A., Fernández‐Barral, A., Bustamante‐Madrid, P., Prieto, I., Rodríguez-Salas, N., Larriba, M. J., & Múñoz, A. (2021) · Cancers · doi:10.3390/cancers13112657 · Cited by 74
Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
Si, X., Xiao, L., Brown, C. E., & Wang, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063154 · Cited by 70
Jeong, S. Y., & Kang, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914609 · Cited by 74
Whelan, K. A., Muir, A. B., & Nakagawa, H. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.011 · Cited by 66
Park, Y., Kim, H., Cho, Y., Min, D., Cheon, S., Lim, Y., Song, S., Kim, S. J., Han, S., Park, K. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31662 · Cited by 66
Organoid models in lung regeneration and cancer
Wang, J., Li, X., & Chen, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.030 · Cited by 67
Organoid models of glioblastoma: advances, applications and challenges.
Zhang, C., Jin, M.-Z., Zhao, J., Chen, J., & Jin, W. (2020) · PubMed Central · Cited by 66
Organoids from adult liver and pancreas: Stem cell biology and biomedical utility
Hindley, C. J., Cordero-Espinoza, L., & Huch, M. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.039 · Cited by 67
Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models
Wu, L., Ai, Y., Xie, R., Xiong, J., Wang, Y., & Liang, Q. (2023) · Lab on a Chip · doi:10.1039/d2lc00804a · Cited by 66
Itraconazole targets cell cycle heterogeneity in colorectal cancer
Buczacki, S. J. A., Popova, S. A., Biggs, E. K., Koukorava, C., Buzzelli, J. N., Vermeulen, L., Hazelwood, L. D., Francies, H. E., Garnett, M. J., & Winton, D. J. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171385 · Cited by 64
Self-citationWill liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall, F. H., Frese, K. K., Simpson, K., Kilgour, E., Brady, G., & Dive, C. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30455-8 · Cited by 66
Organoid Models for Cancer Research
Clevers, H. C., & Tuveson, D. A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055702 · Cited by 69
Self-citationLetizia, M., Wang, Y., Kaufmann, U., Gerbeth, L., Sand, A., Brunkhorst, M., Weidner, P., Ziegler, J., Böttcher, C., Schlickeiser, S., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202215687 · Cited by 60
Tumor organoid biobank-new platform for medical research
Xie, X., Li, X., & Song, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-29065-2 · Cited by 70
Bitar, S. A., El-Sabban, M. E., Doughan, S., & Abou-Kheir, W. G. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i9.1395 · Cited by 69
Cartry, J., Bedja, S., Boilève, A., Mathieu, J. R. R., Gontran, E., Annereau, M., Job, B., Mouawia, A., Mathias, P., de Baère, T., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02853-4 · Cited by 71
Akkerman, N., & Defize, L. H. K. (2017) · BioEssays · doi:10.1002/bies.201600244 · Cited by 65
Recent advances in cancer metabolism: a technological perspective
Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 65
Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
Smith, R. C., & Tabar, V. S. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.11.012 · Cited by 62
Bhola, P. D., Ahmed, E., Guerriero, J. L., Sicińska, E., Su, E., Lavrova, E., Ni, J., Chipashvili, O., Hagan, T., Pioso, M. S., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay1451 · Cited by 66
Codrich, M., Dalla, E., Mio, C., Antoniali, G., Malfatti, M. C., Marzinotto, S., Pierobon, M., Baldelli, E., Loreto, C. D., Damante, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01986-8 · Cited by 63
Laoukili, J., Constantinides, A., Wassenaar, E. C. E., Elias, S. G., Raats, D., van Schelven, S. J., van Wettum, J., Volckmann, R., Köster, J., Huitema, A. D. R., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01742-5 · Cited by 63
Mead, B. E., Hattori, K., Levy, L. E., Imada, S., Goto, N., Vukovic, M., Sze, D., Kummerlowe, C., Matute, J. D., Duan, J., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00863-9 · Cited by 60
The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options
Groenewald, W., Lund, A. H., & Gay, D. M. (2023) · Cells · doi:10.3390/cells12070990 · Cited by 63
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations
Foley, T. M., Payne, S. N., Pasch, C. A., Yueh, A. E., Hey, D. R. V. D., Korkos, D. P., Clipson, L. J., Maher, M. E., Matkowskyj, K. A., Newton, M. A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0256 · Cited by 64
Bioengineering Organs for Blood Detoxification
Legallais, C., Kim, D., Mihaila, S. M., Mihajlovic, M., Figliuzzi, M., Bonandrini, B., Salerno, S., Yengej, F. A. Y., Rookmaaker, M. B., Romero, N. S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800430 · Cited by 67
Microdissected “cuboids” for microfluidic drug testing of intact tissues
Horowitz, L. F., Rodriguez, A. D., Au-Yeung, A., Bishop, K. W., Barner, L. A., Mishra, G., Raman, A., Delgado, P., Liu, J. T. C., Gujral, T. S., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc00801j · Cited by 62
Roelants, C., Pillet, C., Franquet, Q., Sarrazin, C., Peilleron, N., Giacosa, S., Guyon, L., Fontanell, A., Fiard, G., Long, J., et al. (2020) · Cancers · doi:10.3390/cancers12010232 · Cited by 66
Defining the Teratoma as a Model for Multi-lineage Human Development
McDonald, D., Wu, Y., Dailamy, A., Tat, J., Parekh, U., Zhao, D., Hu, M. Y., Tipps, A. M. P., Zhang, K., & Mali, P. (2020) · Cell · doi:10.1016/j.cell.2020.10.018 · Cited by 60
Organoid models of the tumor microenvironment and their applications
Xia, T., Du, W., Chen, X., & Zhang, Y.-N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16578 · Cited by 63
Durinikova, E., Buzo, K., & Arena, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01981-z · Cited by 61
Li, M., Xiao, Q., Venkatachalam, N., Hofheinz, R., Veldwijk, M. R., Herskind, C., Ebert, M. P. A., & Zhan, T. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221077972 · Cited by 62
Chen, L., Wei, X., Gu, D., Xu, Y., & Zhou, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2022.216048 · Cited by 63
Current applications of intestinal organoids: a review
Xiang, T., Wang, J., & Li, H. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03768-3 · Cited by 62
Breaking the mold: 3D cell cultures reshaping the future of cancer research
Cordeiro, S. Z., Oliveira, B. B. P. P., Valente, R., Ferreira, D., Luz, A., Baptista, P. V., & Fernandes, A. R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1507388 · Cited by 70
Lung Cancer Nanomedicine: Potentials and Pitfalls
Bölükbas, D. A., & Meiners, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.155 · Cited by 61
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
Koulis, C., Yap, R. J., Engel, R. M., Jardé, T., Wilkins, S., Solon, J. G., Shapiro, J. D., Abud, H. E., & McMurrick, P. J. (2020) · Cancers · doi:10.3390/cancers12040812 · Cited by 60
Do not keep it simple: recent advances in the generation of complex organoids
Wörsdörfer, P., Ito, T., Asahina, I., Sumita, Y., & Ergün, S. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02198-8 · Cited by 61
New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
Freitas, S. C., Sanderson, D., Caspani, S., Magalhães, R., Cortés‐Llanos, B., Granja, A., Reis, S., Belo, J. H., Azevedo, J., Gómez‐Gaviro, M. V., et al. (2023) · Cancers · doi:10.3390/cancers15020383 · Cited by 60
De Angelis, M. L., Zeuner, A., Policicchio, E., Russo, G., Bruselles, A., Signore, M., Vitale, S., De Luca, G., Pilozzi, E., Boe, A., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0214 · Cited by 60
Kip, A. M., Soons, Z., Mohren, R., Duivenvoorden, A. A. M., Röth, A. A. J., Cillero-Pastor, B., Neumann, U. P., Dejong, C. H. C., Heeren, R. M. A., Olde Damink, S. W. M., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-020-03379-9 · Cited by 55
Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
Azzarelli, R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00220 · Cited by 63
Protocol to profile the bioenergetics of organoids using Seahorse
Ludikhuize, M. C., Meerlo, M., Burgering, B. M. T., & Colman, M. J. R. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100386 · Cited by 68
Zhao, N., Powell, R. T., Yuan, X., Bae, G., Roarty, K. P., Stossi, F., Strempfl, M., Toneff, M. J., Johnson, H. L., Mani, S. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24545-3 · Cited by 65
Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response
Spiller, E. R., Ung, N. M., Kim, S., Patsch, K., Lau, R., Strelez, C., Doshi, C., Choung, S., Choi, B., Juarez, E. F., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.771173 · Cited by 62
Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids
Moura, B. S., Monteiro, M. V., Ferreira, L. P., Lavrador, P., Gaspar, V. M., & Mano, J. F. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202202825 · Cited by 64
Primary human organoids models: Current progress and key milestones
Calà, G., Sina, B., Coppi, P. D., Giobbe, G. G., & Gerli, M. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1058970 · Cited by 62
The role of organoids in cancer research
Fang, Z., Li, P., Du, F., Shang, L., & Li, L. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00433-y · Cited by 68
Gastrointestinal organs and organoids-on-a-chip: advances and translation into the clinics
Carvalho, M. R., Yan, L., Li, B., Zhang, C., He, Y., Reis, R. L., & Oliveira, J. M. (2023) · Biofabrication · doi:10.1088/1758-5090/acf8fb · Cited by 65
Metadata
- Authors
- van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., McLaren-Douglas, A., Blokker, J., Jaksani, S., Bartfeld, S., Volckman, R., van Sluis, P., Li, V. S. W., Seepo, S., Sekhar Pedamallu, C., Cibulskis, K., Carter, S. L., McKenna, A., Lawrence, M. S., Lichtenstein, L., Stewart, C., Koster, J., Versteeg, R., van Oudenaarden, A., Saez-Rodriguez, J., Vries, R. G. J., Getz, G., Wessels, L., Stratton, M. R., McDermott, U., Meyerson, M., Garnett, M. J., & Clevers, H.
- Affiliations
- Wellcome Sanger Institute (GB)
- Broad Institute (US)
- The Netherlands Cancer Institute (NL)
- European Bioinformatics Institute (GB)
- Diakonessenhuis hospital (NL)
- Royal Netherlands Academy of Arts and Sciences (NL)
- National Institute for Medical Research (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Garnett, Mathew J.
- Clevers, Hans
- ORCID
- Francis, Joshua M.
- Iorio, Francesco
- Pronk, Apollo
- Taylor-Weiner, Amaro
- Kester, Lennart
- Bartfeld, Sina
- Li, Vivian S.W.
- Cibulskis, Kristian
- Carter, Scott L.
- McKenna, Aaron
- Lawrence, Michael S.
- Stewart, Chip
- Versteeg, Rogier
- Vries, Robert G.J.
- Getz, Gad
- Wessels, Lodewyk
- Stratton, Michael R.
- McDermott, Ultan
- Meyerson, Matthew
- Garnett, Mathew J.
- Clevers, Hans
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 161
- Issue
- 4
- Pages
- 933-945
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6428276
- OpenAlex
- W1741548448
- Cited by
- 2,408
- References
- 64
- Citations by year
- 2026: 196 · 2025: 233 · 2024: 232 · 2023: 220 · 2022: 267 · 2021: 343 · 2020: 260 · 2019: 181 · 2018: 173 · 2017: 154 · 2016: 108 · 2015: 39
- FWCI
- 69.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- Francis Crick Institute (10105)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- colorectal cancer, tumor organoids, organoid biobank, Lgr5+ stem cells, R-spondin, Wnt signaling, porcupine inhibitor, RNF43 mutation, APC mutation, drug screening, personalized treatment, molecular subtypes, gene expression profiling
- MeSH terms
- DNA-Binding Proteins, Drug Screening Assays, Antitumor, Humans, Organ Culture Techniques, Organoids, Colorectal Neoplasms, Oncogene Proteins, Biological Specimen Banks, Ubiquitin-Protein Ligases, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
